Macrophage, a potential targeted therapeutic immune cell for cardiomyopathy

Area of Science:

• Cardiovascular Biology
• Immunology
• Pathophysiology

Background:

• Cardiomyopathy leads to heart failure via systolic/diastolic dysfunction and cardiac remodeling.
• Macrophages are pivotal immune cells in cardiac inflammation and fibrosis.
• Exogenous and resident cardiac macrophages exhibit distinct functional and phenotypic differences during injury.

Purpose of the Study:

• To elucidate the molecular mechanisms of macrophage involvement in cardiomyopathy.
• To analyze current clinical treatment strategies for myocardial fibrosis.
• To bridge the gap between experimental findings and clinical application of macrophage-targeted therapies.

Main Methods:

• Comprehensive literature review on macrophage function in cardiomyopathy.
• Analysis of existing research on molecular mechanisms.
• Evaluation of clinical treatment strategies and challenges for myocardial fibrosis.

Main Results:

• Macrophages significantly contribute to inflammation and fibrosis in cardiomyopathy.
• Distinct roles of exogenous and resident macrophages in cardiac injury identified.
• Challenges in clinical translation of macrophage-targeted therapies highlighted.

Conclusions:

• Macrophages are critical players in the pathogenesis of cardiomyopathy.
• Targeting macrophages holds therapeutic potential for heart failure and myocardial fibrosis.
• Further research is needed to overcome clinical translation hurdles for macrophage-based interventions.